Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control 2023-03-27 17:34
Everest Medicines Receives Full Upfront Payment from Gilead for Trodelvy-Related Transaction, Boosting Pro Forma Cash Reserves 2023-03-27 08:15
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS 2023-03-25 02:51
World TB Day 2023: Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa 2023-03-24 16:07
Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results 2023-03-24 13:33
EMA Validates Marketing Authorization Application for Henlius' HANSIZHUANG (Serplulimab) 2023-03-24 08:00
Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director 2023-03-24 04:30
Northumbria Healthcare NHSFT and C-POLAR Technologies combine innovation in widely acclaimed hub 2023-03-23 20:32
Everest Medicines Announces Signing of an MOU for Strategic Cooperation with Guangdong Academy of Medical Sciences in Renal Diseases 2023-03-23 17:52
111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results 2023-03-23 14:17
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors 2023-03-23 08:00
Ascentage Pharma Announces 2022 Annual Results Including Strong Sales of Olverembatinib and Steady Progress in Transition Towards Biopharma 2023-03-23 00:22
Jacobio Pharma Announces 2022 Annual Results 2023-03-22 22:38
Daewoong Pharmaceutical's Envlo to enter the global market in full swing with filing for product license in three ASEAN countries 2023-03-22 21:20
CARsgen Announced 2022 Annual Results and Business Updates 2023-03-22 20:50
Biosion bispecific antibody therapies to be featured at the American Association for Cancer Research (AACR) annual meeting 2023 2023-03-22 20:19
WuXi Biologics Reports Remarkable 2022 Annual Results 2023-03-22 20:09
Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer 2023-03-22 12:36
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2% 2023-03-22 11:15
DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM 2023-03-22 09:00
1 79 80 81 82 83 377